Pressurized IntraPeritoneal Aerosol Chemotherapy (PIPAC) Applied to Platinum-Resistant Recurrence of Ovarian Tumor: A Single-Institution Experience (ID: PARROT Trial)

CONCLUSIONS: PIPAC seems a feasible approach for the treatment of this subset of patients, without any impact on their quality of life. Since this study had a small sample size and a single-center design, future research is mandatory, such as its application in addition to systemic chemotherapy.PMID:38099993 | DOI:10.1245/s10434-023-14648-0

Source: Ann Oncol - December 15, 2023 Category: Cancer & Oncology Authors: Giuseppe Vizzielli Maria Teresa Giudice Federica Nardelli Barbara Costantini Vanda Salutari Frediano Socrate Inzani Gian Franco Zannoni Vito Chiantera Andrea Di Giorgio Fabio Pacelli Anna Fagotti Giovanni Scambia Source Type: research